Engineers Gate Manager’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
ACA
Engineers Gate Manager's CYTK Position: Q1 2026 in Review
Engineers Gate Manager sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 111,544 shares — an estimated $7.09M sold.
Engineers Gate Manager first reported a position in CYTK in Q3 2020 and held it in 12 quarters. The position peaked at $7.09M in Q4 2025. 440 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.
- Engineers Gate Manager reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
- Engineers Gate Manager sold 111,544 Cytokinetics shares in Q1 2026, an estimated $7.09M.
- Engineers Gate Manager first reported a position in Cytokinetics in Q3 2020 and held it in 12 quarters.
- Engineers Gate Manager's Cytokinetics position peaked at $7.09M in Q4 2025.
- 440 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.
Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.